Dr. Lal Pathlabs Ltd. Investor Presentation

Dr. Lal Pathlabs Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Dr. Lal Pathlabs Ltd.
12 Nov 2018, 02:44PM
2926.50
-0.10%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Regulations'), please find attached herewith Corporate Presentation of the Company for Q2 H1 FY19. The aforesaid presentation will also be available on the Company's website- www.lalpathlabs.com. We request you to please take the same on record.
pdf
logo
Dr. Lal Pathlabs Ltd.
06 Nov 2018
2926.50
-0.10%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Please find attached a copy of Company''s Q2 & H1 FY19 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2018.
pdf
logo
Dr. Lal Pathlabs Ltd.
16 Aug 2018
2926.50
-0.10%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Regulations'), please find attached herewith Corporate Presentation of the Company for Q1 FY19. The aforesaid presentation is also available on the Company's website - www.lalpathlabs.com We request you to please take the same on record.
pdf
logo
Dr. Lal Pathlabs Ltd.
10 Aug 2018
2926.50
-0.10%
pdf
logo
Dr. Lal Pathlabs Ltd.
14 May 2018
2926.50
-0.10%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Please find attached a copy of Company's Q4/FY18 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2018, approved by the Board of Directors in their meeting held on May 14, 2018.
pdf
logo
Dr. Lal Pathlabs Ltd.
19 Feb 2018
2926.50
-0.10%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Dear Sir/Madam, This is in furtherance to our letter dated February 9, 2018, wherein we shared the Corporate Presentation of the Company. In this respect, please take note that there was a small typographical error in the 4th block on page no 6, wherein it was inadvertently mentioned '22.1 mn patients' instead of '11.4 mn patients'...
pdf
logo
Dr. Lal Pathlabs Ltd.
09 Feb 2018
2926.50
-0.10%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Regulations'), please find attached herewith Corporate Presentation of the Company, which the Company proposes to share with analysts/investors. The aforesaid presentation is also available on the Company's website - www.lalpathlabs.com
pdf
logo
Dr. Lal Pathlabs Ltd.
08 Feb 2018
2926.50
-0.10%
Investor Presentation
BSE India
Dear Sir/Madam, Please find attached a copy of Company's Q3 9M FY18 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2017. We request you to please take the same on record.
pdf
logo
Dr. Lal Pathlabs Ltd.
10 Nov 2017
2926.50
-0.10%
Investor Presentation
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Regulations'), please find attached herewith Corporate Presentation of the Company, which the Company proposes to share with analysts/investors.
pdf
logo
Dr. Lal Pathlabs Ltd.
09 Nov 2017
2926.50
-0.10%
Investor Presentation
BSE India
Investors Presentation on Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2017
pdf